A new study supported by ERN RITA and the Paediatric Rheumatology European Society (PReS) explores the diagnosis, treatment, and monitoring of interleukin-1 (IL-1) mediated autoinflammatory diseases across ten Central and Eastern European countries.
The research compares current clinical practices with the 2021 EULAR/ACR recommendations, highlighting areas of alignment as well as ongoing challenges—particularly in access to specialised tests, IL-1 inhibitors, and structured transition care.
This collaborative effort, involving ERN RITA full and affiliated members, provides valuable real-world data and sheds light on healthcare disparities that impact the implementation of standardised care across the region.
